Patterson Cos. (PDCO) Up 0.3% Since Last Earnings Report: Can It Continue?
Patterson Cos. (PDCO) reported earnings 30 days ago.
PDCO Q3 Earnings & Sales Miss Estimates, Margins Contract
Patterson Companies' overall top-line figure for the third quarter of fiscal 2025 reflects weak segmental performance.
Patterson Cos. (PDCO) Q3 Earnings and Revenues Lag Estimates
Patterson Cos. (PDCO) came out with quarterly earnings of $0.43 per share, missing the Zacks Consensus Estimate of $0.62 per share.
PDCO Stock Gains on the News of Acquisition Deal With Patient Square
Patterson enters into a definitive agreement to be acquired by Patient Square Capital at a valuation of approximately $4.1 billion.
What Does Dental Player Patterson's $4.1 Billion Deal Mean For Other Players?
On Wednesday, Patient Square Capital, a healthcare investment firm, agreed to acquire Patterson Companies, Inc. PDCO, a dental and animal health product distributor, for approximately $4.1 billion.
Patterson Companies Surges As The Market Prices In More Upside (Rating Downgrade)
Patterson Companies' shares surged 35.9% after announcing an all-cash buyout by Patient Square Capital, valuing the company at $4.1 billion. Despite the buyout, some investors feel the deal leaves money on the table, but the stock's appreciation is a net positive. The go-shop period allows management to seek better offers, suggesting potential for a higher bid, making it wise to hold shares.
Dental Product Supplier Patterson Companies Goes Private In $4.1 Billion Deal
On Wednesday, Patient Square Capital, a healthcare investment firm, agreed to acquire Patterson Companies, Inc. PDCO, a dental and animal health product distributor, for approximately $4.1 billion.
Patterson Cos. to Be Acquired by Patient Square Capital for $4.1 Billion
Shareholders will receive $31.35 in cash per share under terms of the deal.
PDCO Stock Gains Despite Q2 Earnings Miss and Lower Margins
Patterson Companies' overall topline in the second quarter of fiscal 2025 benefits from strength in its Animal Health segment.
Patterson Companies, Inc. (PDCO) Q2 2025 Earnings Call Transcript
Patterson Companies, Inc. (NASDAQ:PDCO ) Q2 2025 Earnings Conference Call December 5, 2024 8:30 AM ET Company Participants John Wright - Vice President, Investor Relations Don Zurbay - President and Chief Executive Officer Kevin Barry - Chief Financial Officer Conference Call Participants Michael Cherny - Leerink Partners Jeffrey Johnson - Baird Kevin Caliendo - UBS Jonathan Block - Stifel Erin Wright - Morgan Stanley Jason Bednar - Piper Sandler Sameer Patel - Evercore ISI Allen Lutz - Bank of America Steven Valiquette - Mizuho Securities Brandon Vazquez - William Blair Operator Thank you for standing by and welcome to the Patterson Companies' Second Quarter Fiscal 2025 Earnings Conference Call. All lines have been placed on mute to prevent any background noise.
Dental Supplier Patterson Companies Is Up For Sale After Posting Mixed Q2 Earnings
Dental supply maker Patterson Companies Inc PDCO announced Thursday that it is exploring strategic options, including a sale or merger, to boost shareholder value.
Compared to Estimates, Patterson Cos. (PDCO) Q2 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Patterson Cos. (PDCO) give a sense of how the business performed in the quarter ended October 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
